These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 1930356

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [In vitro study of estradiol-linked nitrosourea in breast cancers in the mouse, rat and human: interspecies comparison].
    Petru E, Berger MR, Zeller WJ, Kaufmann M.
    Wien Klin Wochenschr; 1989 Feb 17; 101(4):130-4. PubMed ID: 2538970
    [Abstract] [Full Text] [Related]

  • 3. Hexadecylphosphocholine differs from conventional cytostatic agents.
    Berger MR, Betsch B, Gebelein M, Amtmann E, Heyl P, Scherf HR.
    J Cancer Res Clin Oncol; 1993 Feb 17; 119(9):541-8. PubMed ID: 8392075
    [Abstract] [Full Text] [Related]

  • 4. Cytotoxic effects of hexadecylphosphocholine in neoplastic cell lines including drug-resistant sublines in vitro.
    Danhauser-Riedl S, Himmelmann A, Steinhauser G, Busch R, Vogler WR, Rastetter J, Berdel WE.
    J Lipid Mediat; 1990 Feb 17; 2(5):271-80. PubMed ID: 2133272
    [Abstract] [Full Text] [Related]

  • 5. Effect of miltefosine on transplanted methylnitrosourea-induced mammary carcinoma growing in Fischer 344 rats.
    Reinhardt M, Heyl P, Amelung F, Berger MR.
    Arzneimittelforschung; 1992 Oct 17; 42(10):1239-42. PubMed ID: 1282010
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Evaluation of spin labeled TEPA and CCNU analogs against osteosarcoma and MNU-induced mammary carcinoma of the SD-rat.
    Klenner T, Berger MR, Sosnovsky G, Rao NU, Wingen F, Schmähl D.
    Arch Geschwulstforsch; 1989 Oct 17; 59(4):251-6. PubMed ID: 2478094
    [Abstract] [Full Text] [Related]

  • 8. Morphological and immunological observations on the effects of hexadecylphosphocholine (HPC) in nude mice bearing MT-1 breast cancer xenografts.
    Safa O, Parkin SM, Matthew AM, Bibby MC.
    Anticancer Res; 1997 Oct 17; 17(1A):37-43. PubMed ID: 9066628
    [Abstract] [Full Text] [Related]

  • 9. Retinoid feeding, hormone inhibition, and/or immune stimulation and the progression of N-methyl-N-nitrosourea-induced rat mammary carcinoma: suppression by retinoids of peptide hormone-induced tumor cell proliferation in vivo and in vitro.
    Welsch CW, DeHoog JV, Scieszka KM, Aylsworth CF.
    Cancer Res; 1984 Jan 17; 44(1):166-71. PubMed ID: 6360344
    [Abstract] [Full Text] [Related]

  • 10. Sulfone metabolite of sulindac inhibits mammary carcinogenesis.
    Thompson HJ, Jiang C, Lu J, Mehta RG, Piazza GA, Paranka NS, Pamukcu R, Ahnen DJ.
    Cancer Res; 1997 Jan 15; 57(2):267-71. PubMed ID: 9000566
    [Abstract] [Full Text] [Related]

  • 11. Influence of schedule on alkylating agent cytotoxicity in vitro and in vivo.
    Teicher BA, Holden SA, Eder JP, Brann TW, Jones SM, Frei E.
    Cancer Res; 1989 Nov 01; 49(21):5994-8. PubMed ID: 2790813
    [Abstract] [Full Text] [Related]

  • 12. [Cytotoxicity of lipid ether ilmofosine in combination with radiotherapy in vitro].
    Neumann HA, Lichtinghagen R, Borchardt D, Kissler M.
    Strahlenther Onkol; 1991 Apr 01; 167(4):250-3. PubMed ID: 2028404
    [Abstract] [Full Text] [Related]

  • 13. Alkyl phosphocholines: toxicity and anticancer properties.
    Muschiol C, Berger MR, Schuler B, Scherf HR, Garzon FT, Zeller WJ, Unger C, Eibl HJ, Schmähl D.
    Lipids; 1987 Nov 01; 22(11):930-4. PubMed ID: 3444388
    [Abstract] [Full Text] [Related]

  • 14. Cytostatic activity of an estradiol-linked nitrosourea in MXT mammary carcinoma and L 5222 leukemia.
    Zeller WJ, Schreiber J, Petru E, Eisenbrand G.
    Arzneimittelforschung; 1989 Dec 01; 39(12):1577-9. PubMed ID: 2624608
    [Abstract] [Full Text] [Related]

  • 15. [Chemotherapeutic characterization of new nitrosourea compounds].
    Zeller WJ, Berger MR, Eisenbrand G, Petru E.
    Arch Geschwulstforsch; 1988 Dec 01; 58(3):137-49. PubMed ID: 3415433
    [Abstract] [Full Text] [Related]

  • 16. Potent growth inhibitory activity of zidovudine on cultured human breast cancer cells and rat mammary tumors.
    Wagner CR, Ballato G, Akanni AO, McIntee EJ, Larson RS, Chang S, Abul-Hajj YJ.
    Cancer Res; 1997 Jun 15; 57(12):2341-5. PubMed ID: 9192804
    [Abstract] [Full Text] [Related]

  • 17. Structure-activity relationships of alkylphosphocholine derivatives: antineoplastic action on brain tumor cell lines in vitro.
    Jendrossek V, Hammersen K, Erdlenbruch B, Kugler W, Krügener R, Eibl H, Lakomek M.
    Cancer Chemother Pharmacol; 2002 Jul 15; 50(1):71-9. PubMed ID: 12111115
    [Abstract] [Full Text] [Related]

  • 18. N-methyl-N-nitrosourea-induced rat mammary tumors. Hormone responsiveness but lack of spontaneous metastasis.
    Williams JC, Gusterson B, Humphreys J, Monaghan P, Coombes RC, Rudland P, Neville AM.
    J Natl Cancer Inst; 1981 Jan 15; 66(1):147-55. PubMed ID: 6779042
    [Abstract] [Full Text] [Related]

  • 19. Interaction of nicotine with anticancer treatment.
    Berger MR, Zeller WJ.
    Klin Wochenschr; 1988 Jan 15; 66 Suppl 11():127-33. PubMed ID: 3184771
    [Abstract] [Full Text] [Related]

  • 20. Flavopiridol (L86-8275): selective antitumor activity in vitro and activity in vivo for prostate carcinoma cells.
    Drees M, Dengler WA, Roth T, Labonte H, Mayo J, Malspeis L, Grever M, Sausville EA, Fiebig HH.
    Clin Cancer Res; 1997 Feb 15; 3(2):273-9. PubMed ID: 9815683
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.